Previously, MASM was shown to exhibit potent anti-inflammatory, immunomodulatory and inhibitory activity against liver fibrosis in vitro and in vivo, along with the reduction of Akt phosphorylation15–17. Here, AKT1 is linked to Hepatic fibrosis.